GDEV Inc. (NASDAQ: GDEV) files supplement for 982,615 share resale by insiders

Rhea-AI Filing Summary

GDEV Inc. has filed a prospectus supplement allowing certain affiliates to resell up to 982,615 ordinary shares issued or issuable under its 2021 Employee Stock Option Plan. These shares may be sold from time to time by the named Selling Shareholders in various transaction types and at varying prices.

GDEV is not selling any shares in this offering and will not receive proceeds from resale of the ordinary shares, other than any cash paid upon exercise of options that carry an exercise price. Ordinary shares outstanding were 18,150,489 as of the supplement date; this is a baseline figure, not the amount being offered. The supplement updates the list of Selling Shareholders and their respective resale amounts, including executives and directors, and replaces the prior prospectus supplement no. 1.

The ordinary shares trade on the Nasdaq Global Market under the symbol GDEV, and the last reported sale price on July 28, 2026 was $11.81 per share.

Filing Explained

The filing expands registered resale capacity; any dilution depends on option exercise and issuance, while seller timing and volume remain open.

Form 424B3 prospectus supplement no. 2 updates the registration for future resales by named affiliates, replaces supplement no. 1, and covers up to 982,615 ordinary shares.

Although the supplement describes an offer and sale, the disclosed state is future, continuous or delayed resale: options may first need to be exercised, and no completed issuance or sale is established. If option shares are issued, the share count could rise and existing holders’ percentage ownership could fall.

The table includes 387,381 shares offered by Anton Reinhold, 80,000 option shares plus 1,650 held by CFO Alexander Karavaev, and 7,906, 8,418, and 18,560 shares for directors Marie Holive, Andrew Sheppard, and Tal Shoham, respectively.

The selling shareholders may sell any, all, or none at fixed, market-based, varying, or negotiated prices; they bear selling commissions, while GDEV bears registration expenses and receives proceeds only from options carrying an exercise price when exercised.

Key Figures

Registered resale amount: 982,615 ordinary shares Shares outstanding: 18,150,489 ordinary shares Nasdaq last reported price: $11.81 per share +2 more

5 metrics

Registered resale amount 982,615 ordinary shares Maximum ordinary shares offered for resale by Selling Shareholders under the reoffer prospectus

Shares outstanding 18,150,489 ordinary shares Aggregate ordinary shares outstanding as of the date of the prospectus supplement

Nasdaq last reported price $11.81 per share Last reported sale price of ordinary shares on Nasdaq on July 28, 2026

CFO total position pre-offering 81,650 ordinary shares Includes 1,650 shares held and 80,000 shares issuable via options for Alexander Karavaev

CEO Nexters Global position pre-offering 387,381 ordinary shares Includes 365,309 shares held and 22,072 shares issuable via options for Anton Reinhold

Key Terms

Reoffer Prospectus, control securities, Plan of Distribution, Selling Securityholders, +1 more

5 terms

Reoffer Prospectus regulatory

"This prospectus supplement no. 2 amends and supplements the prospectus dated October 18, 2023 (the “Reoffer Prospectus”)"

A reoffer prospectus is the final sales document underwriters use when they put newly issued securities up for public sale, listing the exact price, number of shares, and key terms. Think of it like a detailed product label or brochure for an offering: it tells investors what is being sold, how much it costs, and the main risks, so buyers can compare deals and make informed investment choices.

control securities regulatory

"The ordinary shares that will be issued to the Selling Shareholders under the Plan will be “control securities” under the Securities Act"

Plan of Distribution regulatory

"See “Plan of Distribution” beginning on page 6 of the Reoffer Prospectus for more information"

Selling Securityholders regulatory

"relates to the offer and sale, from time to time, by the Selling Securityholders"

Selling securityholders are existing owners of a company's stocks or other tradable claims who are offering some or all of their holdings for sale in a public offering or secondary transaction. Investors watch these sellers because large or insider sales can increase the number of shares available, put downward pressure on price, and signal insiders’ views about future prospects—much like many people selling tickets at once can change the market for an event.

Rule 424(b)(3) regulatory

"Filed Pursuant to Rule 424(b)(3) Registration No. 333-261757"

Rule 424(b)(3) is a U.S. Securities and Exchange Commission filing rule that governs how updated prospectus information about a securities offering is formally added to an existing registration statement. For investors, seeing a 424(b)(3) filing means the company has officially recorded new offering details – like the number of shares, pricing range or other terms – so it’s a reliable place to check the latest, legally required disclosures; think of it as the official addendum to a product manual that must be filed before the product is sold.

Offering Details

secondary

Offering

Offering Type secondary

Use of Proceeds No proceeds from resales; issuer may receive amounts, if any, paid upon exercise of options under the 2021 Employee Stock Option Plan that carry an exercise price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/29/2026 - 04:28 PM Accepted by SEC EDGAR 07/29/2026 - 04:01 PM Learn about SEC filing dates

FAQ

What is GDEV (GDEV) registering in this new prospectus supplement?

GDEV is registering up to 982,615 ordinary shares for resale by affiliated Selling Shareholders. These shares are issued or issuable under the 2021 Employee Stock Option Plan and may be sold on a continuous or delayed basis.

Does GDEV (GDEV) receive any cash from the resale of these 982,615 shares?

GDEV will not receive proceeds from Selling Shareholders’ resales, but may receive cash upon option exercise for options with an exercise price. Only the Selling Shareholders receive proceeds from subsequent public sales of the shares.

How many GDEV (GDEV) ordinary shares are currently outstanding?

GDEV states that 18,150,489 ordinary shares were outstanding as of the date of the prospectus supplement. This figure is used to calculate ownership percentages and is separate from the 982,615 shares registered for resale.

Who are some of the key Selling Shareholders in GDEV (GDEV)’s supplement?

Named Selling Shareholders include Alexander Karavaev (CFO), Anton Reinhold (CEO of Nexters Global Ltd.), and directors Marie Holive, Andrew Sheppard, and Tal Shoham, each with specific option-based share positions.

What is the latest reported market price for GDEV (GDEV) ordinary shares?

The supplement notes that GDEV’s ordinary shares traded on Nasdaq at a last reported sale price of $11.81 per share on July 28, 2026. This provides investors with a recent reference price for the registered shares.

How can GDEV (GDEV) Selling Shareholders sell their registered shares?

Selling Shareholders may sell shares in one or more transactions at fixed, market, related, varying, or negotiated prices, through underwriters, dealers, broker-dealers, or directly to purchasers, as described in the Plan of Distribution.

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-261757

PROSPECTUS SUPPLEMENT No. 2
(to Reoffer Prospectus dated October 18, 2023)

GDEV Inc.

 

982,615 ORDINARY SHARES

This prospectus supplement no. 2 amends and supplements the prospectus dated October 18, 2023 (the “Reoffer Prospectus”) of GDEV Inc. (together with its subsidiaries, the “Company,” “we,” “us” or “our”), which forms part of the Company’s registration statement on Form S-8 (File No. 333-261757). The Reoffer Prospectus, as supplemented by this prospectus supplement no. 2, relates to the offer and sale, from time to time, by the Selling Securityholders (as defined in the Reoffer Prospectus), or their permitted transferees, of (i) up to 982,615 of our ordinary shares, no par value per share (the “ordinary shares”) issued to the Selling Securityholders pursuant to options granted to the Selling Shareholders under GDEV’s 2021 Employee Stock Option Plan, as amended from time to time (the “Plan”). This prospectus supplement no. 2 to the Reoffer Prospectus supersedes prospectus supplement no. 1 to the Reoffer Prospectus, which was filed pursuant to Rule 424(b)(3) with the Securities and Exchange Commission on November 13, 2024.

This prospectus supplement updates and supplements the information in the Reoffer Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Reoffer Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Reoffer Prospectus and if there is any inconsistency between the information in the Reoffer Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

We are not offering any of the ordinary shares and will not receive any proceeds from the sale of the ordinary shares offered by the Reoffer Prospectus, as updated and supplemented by this prospectus supplement, except with respect to amounts, if any, received by us upon exercise of the options granted under the Plan that are subject to the payment of an exercise price. See “Use of Proceeds” in the Reoffer Prospectus.

Upon the issuance of the ordinary shares issuable upon exercise of options granted to the Selling Shareholders under the Plan, the Selling Shareholders may from time to time sell, transfer or otherwise dispose of any or all of the ordinary shares covered by the Reoffer Prospectus, as updated and supplemented by this prospectus supplement, though underwriters or dealers, directly to purchasers (or a single purchaser) or through broker-dealers or agents. If underwriters or dealers are used to sell the shares, we will name them and describe their compensation in a prospectus supplement. The ordinary shares may be sold in one or more transactions at fixed prices, prevailing market prices at the time of sale, prices related to the prevailing market prices, varying prices determined at the time of sale or negotiated prices. We do not know when or in what amount the Selling Shareholders may offer the shares for sale. The Selling Shareholders may sell any, all or none of the shares offered by the Reoffer Prospectus, as updated and supplemented by this prospectus supplement. See “Plan of Distribution” beginning on page 6 of the Reoffer Prospectus for more information about how the Selling Shareholders may sell or dispose of the ordinary shares covered by the Reoffer Prospectus, as updated and supplemented by this prospectus supplement. The Selling Shareholders will bear all sales commissions and similar expenses. We will bear all expenses of registration incurred in connection with this offering, including any other expenses incurred by us in connection with the registration and offering that are not borne by the Selling Shareholders.

The Selling Shareholders are “affiliates” of GDEV (as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”)). The ordinary shares that will be issued to the Selling Shareholders under the Plan will be “control securities” under the Securities Act before their sale under the Reoffer Prospectus, as updated and supplemented by this prospectus supplement. The Reoffer Prospectus, as updated and supplemented by this prospectus supplement, has been prepared for the purposes of registering the ordinary shares under the Securities Act to allow for future sales by the Selling Shareholders on a continuous or delayed basis to the public without restriction.

Our ordinary shares are listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “GDEV.” On July 28, 2026, the last reported sale price of our ordinary shares as reported on Nasdaq was $11.81 per share.

Investing in our securities involves a high degree of risk. For a discussion of information that should be considered in connection with an investment in our securities, see “Risk Factors” beginning on page 4 of the Reoffer Prospectus and the risk factors contained in any document incorporated by reference in the Reoffer Prospectus and any applicable prospectus supplement.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if the Reoffer Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is July 29, 2026.

EXPLANATORY NOTE

This prospectus supplement no. 2 updates and supplements the Reoffer Prospectus to amend and restate the table of the Selling Securityholders on pages 5 and 6 of the Reoffer Prospectus to update the list of Selling Securityholders named in the Reoffer Prospectus and the amounts of ordinary shares available to be resold by them. This prospectus supplement no. 2 to the Reoffer Prospectus supersedes prospectus supplement no. 1 to the Reoffer Prospectus, which was filed pursuant to Rule 424(b)(3) with the Securities and Exchange Commission on November 13, 2024.

Table of Selling Securityholders

		Ordinary Shares
Name of Selling Securityholder		Shares Owned Before the Offering(1)				Shares Owned Before the Offering (%)(2)				Shares to be Sold(3)				Shares Owned After the Offering				Shares Owned After the Offering (%)(4)
Alexander Karavaev(5)			81,650	(6)			*				80,000				1,650				*
Anton Reinhold(7)			387,381	(8)			2.1				387,381				—				—
Marie Holive(9)			7,906	(10)			*				7,906				—				—
Andrew Sheppard(11)			8,418	(12)			*				8,418				—				—
Tal Shoham(13)			18,560	(10)			*				18,560				—				—

	*	Less than one percent (1%)
	(1)	The number of ordinary shares listed for each Selling Shareholder is based on the ordinary shares held by such Selling Shareholder as of the date of this prospectus supplement, but assumes the exercise of all options held by such Selling Shareholder and are currently exercisable or exercisable within 60 days of the date of this prospectus supplement.
	(2)	In calculating the percentages, (a) the numerator is calculated by adding the number of ordinary shares held by such Selling Shareholders as of the date of this prospectus supplement and the number of ordinary shares issuable upon the exercise of options held by such Selling Shareholder and are currently exercisable or exercisable within 60 days of the date of this prospectus supplement, if any; and (b) the denominator is calculated by adding the aggregate number of ordinary shares outstanding as of the date of this prospectus supplement (being 18,150,489 ordinary shares) and the number of ordinary shares issuable upon the exercise of options held by such Selling Shareholder and are currently exercisable or exercisable within 60 days of the date of this prospectus supplement, if any (but not the number of ordinary shares issuable upon the exercise of options held by any other Selling Shareholder).
	(3)	The number of shares to be sold includes (a) the ordinary shares held by such Selling Shareholder as of the date of this prospectus supplement and offered hereby, and (b) the ordinary shares issuable to such Selling Shareholder and offered hereby.
	(4)	In calculating the percentages, (a) the numerator is based on the number of ordinary shares included under the column “Shares Owned After the Offering,” and (b) the denominator is calculated by adding the aggregate number of ordinary shares outstanding as of the date of this prospectus supplement (being 18,150,489 ordinary shares) and the number of ordinary shares issuable upon the exercise of options held by such Selling Shareholder and are currently exercisable or exercisable within 60 days of the date of this prospectus supplement, if any (but not the number of ordinary shares issuable upon the exercise of options held by any other Selling Shareholder).
	(5)	Alexander Karavaev is Chief Financial Officer of the Company, whose business address is 55, Griva Digeni, Limassol, Cyprus.
	(6)	Includes (i) 1,650 ordinary shares currently held as of the date of this prospectus supplement and (ii) 80,000 ordinary shares issuable pursuant to options granted under the Plan that are currently exercisable or exercisable within 60 days of the date of this prospectus supplement.
	(7)	Anton Reinhold is the Chief Executive Officer of Nexters Global Ltd., whose business address is 55, Griva Digeni, Limassol, Cyprus.
	(8)	Includes (i) 365,309 ordinary shares currently held as of the date of this prospectus supplement and (ii) 22,072 ordinary shares issuable pursuant to options granted under the Plan that are currently exercisable or exercisable within 60 days of the date of this prospectus supplement.
	(9)	Marie Holive is a director of the Company, whose business address is 55, Griva Digeni, Limassol, Cyprus.
	(10)	Comprises ordinary shares issuable upon the exercise of options granted under the Plan that are currently exercisable.
	(11)	Andrew Sheppard is a director of the Company, whose business address is 55, Griva Digeni, Limassol, Cyprus.
	(12)	Includes (i) 512 ordinary shares currently held as of the date of this prospectus supplement and (ii) 7,906 ordinary shares issuable pursuant to options granted under the Plan that are currently exercisable or exercisable within 60 days of the date of this prospectus supplement.
	(13)	Tal Shoham is a director of the Company, whose business address is 55, Griva Digeni, Limassol, Cyprus.